Fomepizole as a therapeutic strategy in paediatric methanol poisoning. A case report and review of the literature

Eur J Pediatr. 2005 Mar;164(3):158-61. doi: 10.1007/s00431-004-1588-5. Epub 2004 Dec 1.

Abstract

Methanol poisoning is not frequently observed in children; however, without treatment, serious intoxication can be complicated by visual impairment, coma, metabolic acidosis, respiratory and circulatory insufficiency and death. Treatment in a paediatric intensive care is therefore compulsory. Methanol is metabolised in the liver by alcohol dehydrogenase to the toxic metabolites formaldehyde and formic acid. Classically, ethanol is given as a competitive inhibitor in order to avoid the formation of these compounds. We report on the use of fomepizole (4-methylpyrazole),a new and potent inhibitor of alcohol dehydrogenase, in a 3-year-old boy after the intake of a toxic amount of methanol. The course was uneventful and the use of fomepizole was not accompanied by any side-effects. An overview is given of all cases of paediatric poisoning in which fomepizole was used.

Conclusion: Fomepizole seems to be a safe and valid alternative to ethanol in cases of paediatric methanol poisoning.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Antidotes / therapeutic use*
  • Child, Preschool
  • Drug Therapy, Combination
  • Fomepizole
  • Humans
  • Leucovorin / therapeutic use
  • Male
  • Methanol / poisoning*
  • Poisoning / drug therapy
  • Pyrazoles / therapeutic use*
  • Solvents / poisoning*

Substances

  • Antidotes
  • Pyrazoles
  • Solvents
  • Fomepizole
  • Leucovorin
  • Methanol